Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/2/24 16:43 | 11/29/24 | DGX | Health | Health | Medical Laboratories | Prevoznik Michael E | NJ | O | SVP,GC | 2 | M.d | 8,776 | 124.85 | 0 | 70 | 44 | D | |||||||||||||||
12/2/24 16:43 | 11/29/24 | DGX | Health | Health | Medical Laboratories | Prevoznik Michael E | NJ | O | SVP,GC | 2 | S.d | -8,776 | 124.85 | 0 | -70 | 44 | D | |||||||||||||||
12/2/24 16:41 | 11/27/24 | DGX | Health | Health | Medical Laboratories | Doherty Catherine T. | NJ | O | EVP,Regi | 2 | M.d | 8,824 | 133.28 | 0 | 66 | 999% | 73 | D | ||||||||||||||
12/2/24 16:41 | 11/27/24 | DGX | Health | Health | Medical Laboratories | Doherty Catherine T. | NJ | O | EVP,Regi | 2 | S.d | -8,824 | 133.28 | 0 | -66 | 73 | D | |||||||||||||||
11/7/24 17:21 | 11/6/24 | DGX | Health | Health | Medical Laboratories | Deppe Michael J | NJ | O | SVP,Corp | 2 | M.d | 4,177 | 111.35 | 0 | 38 | 36 | D | |||||||||||||||
11/7/24 17:21 | 11/6/24 | DGX | Health | Health | Medical Laboratories | Deppe Michael J | NJ | O | SVP,Corp | 2 | S.d | -4,177 | 111.35 | 0 | -38 | 36 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |